Perritt Capital Management Inc Amgen Inc Transaction History

Perritt Capital Management Inc

$185 Million
Q3 2024

A detailed history of Perritt Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Perritt Capital Management Inc holds 2,473 shares of AMGN stock, worth $672,928. This represents 0.43% of its overall portfolio holdings.

Number of Shares

2,473

Previous 2,487 0.56%

Holding current value

$672,928

Previous $777,000 2.45%

% of portfolio

0.43%

Previous 0.45%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $4,331 - $4,723	-14 Reduced 0.56%	2,473 $796,000
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $525 - $638	-2 Reduced 0.08%	2,487 $777,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $3,226 - $3,894	-12 Reduced 0.48%	2,489 $707,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $190,752 - $215,191	-746 Reduced 22.98%	2,501 $720,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $2,186 - $2,714	-10 Reduced 0.31%	3,247 $872,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $61,066 - $72,210	285 Added 9.59%	3,257 $723,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $11,289 - $13,760	-50 Reduced 1.65%	2,972 $718,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $2,977 - $3,783	-13 Reduced 0.43%	3,022 $793,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $5,387 - $6,075	-24 Reduced 0.78%	3,035 $684,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $6,229 - $6,931	27 Added 0.89%	3,059 $744,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $7,674 - $8,489	35 Added 1.17%	3,032 $733,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $17,501 - $20,028	88 Added 3.03%	2,997 $674,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $164,296 - $192,493	774 Added 36.25%	2,909 $619,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $3,970 - $4,405	17 Added 0.8%	2,135 $520,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $6,435 - $7,499	-29 Reduced 1.35%	2,118 $527,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $20,988 - $24,993	-97 Reduced 4.32%	2,147 $494,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $25,576 - $28,443	-109 Reduced 4.63%	2,244 $570,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $54,397 - $66,753	-275 Reduced 10.46%	2,353 $555,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $9,112 - $12,085	-50 Reduced 1.87%	2,628 $533,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $3,784 - $4,864	-20 Reduced 0.74%	2,678 $646,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $2,263 - $2,712	-13 Reduced 0.48%	2,698 $522,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $2,167 - $2,540	13 Added 0.48%	2,711 $515,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $2,167 - $2,540	-13 Reduced 0.48%	2,698 $497,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $45,217 - $50,970	-250 Reduced 8.44%	2,711 $515,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $3,568 - $4,165	20 Added 0.68%	2,961 $576,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $19,145 - $22,374	-113 Reduced 3.7%	2,941 $511,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $510,903 - $583,314	3,054	3,054 $569,000

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Amgen Inc Transaction History